DexCom Historical Income Statement

DXCM Stock

USD 75.32 1.52 2.06%

Historical analysis of DexCom income statement accounts such as Operating Income of 630 M or Ebit of 654.1 M can show how well DexCom Inc performed in making a profits. Evaluating DexCom income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of DexCom's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining DexCom Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DexCom Inc is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About DexCom Income Statement Analysis

DexCom Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to DexCom shareholders. The income statement also shows DexCom investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

DexCom Income Statement Chart

At this time, DexCom's Net Income is very stable compared to the past year. As of the 24th of March 2025, Income Tax Expense is likely to grow to about 139.4 M, while Interest Expense is likely to drop about 15.7 M.

Research Development Total Operating Expenses Income Tax Expense Depreciation And Amortization Selling General Administrative

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Most accounts from DexCom's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into DexCom Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

DexCom income statement Correlations

	Interest Expense	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Depreciation And Amortization	Selling General Administrative	Income Before Tax	Total Other Income Expense Net	Selling And Marketing Expenses	Total Revenue	Gross Profit	Cost Of Revenue	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Interest Expense		0.38	0.27	0.31	0.57	0.29	0.43	0.35	-0.38	0.22	0.32	0.19	0.19	0.32	0.37	0.41	0.31	0.36	0.19	-0.37	0.01	-0.5	0.27	0.66
Other Operating Expenses	0.38		0.92	0.93	0.94	0.95	1.0	0.9	0.49	0.97	0.99	0.32	0.29	0.98	1.0	1.0	0.99	0.9	0.67	0.49	0.85	0.51	0.91	0.85
Operating Income	0.27	0.92		0.99	0.76	0.99	0.88	0.98	0.45	0.95	0.92	0.18	0.15	0.95	0.94	0.94	0.95	0.98	0.53	0.45	0.89	0.61	0.91	0.7
Ebit	0.31	0.93	0.99		0.8	1.0	0.91	0.97	0.47	0.96	0.92	0.19	0.16	0.96	0.95	0.95	0.96	0.97	0.53	0.47	0.89	0.59	0.93	0.74
Research Development	0.57	0.94	0.76	0.8		0.82	0.97	0.75	0.35	0.86	0.91	0.36	0.34	0.89	0.92	0.94	0.89	0.76	0.63	0.35	0.65	0.25	0.82	0.91
Ebitda	0.29	0.95	0.99	1.0	0.82		0.92	0.96	0.5	0.97	0.94	0.21	0.17	0.98	0.97	0.96	0.97	0.96	0.54	0.5	0.9	0.6	0.94	0.74
Total Operating Expenses	0.43	1.0	0.88	0.91	0.97	0.92		0.86	0.46	0.95	0.98	0.35	0.32	0.96	0.99	0.99	0.98	0.87	0.66	0.46	0.8	0.44	0.9	0.87
Net Income	0.35	0.9	0.98	0.97	0.75	0.96	0.86		0.27	0.91	0.89	0.19	0.15	0.92	0.92	0.91	0.92	1.0	0.53	0.27	0.85	0.53	0.87	0.73
Income Tax Expense	-0.38	0.49	0.45	0.47	0.35	0.5	0.46	0.27		0.57	0.51	0.05	0.04	0.53	0.48	0.46	0.52	0.27	0.3	1.0	0.65	0.74	0.53	0.16
Depreciation And Amortization	0.22	0.97	0.95	0.96	0.86	0.97	0.95	0.91	0.57		0.97	0.25	0.22	0.99	0.98	0.97	0.98	0.91	0.57	0.57	0.89	0.63	0.93	0.73
Selling General Administrative	0.32	0.99	0.92	0.92	0.91	0.94	0.98	0.89	0.51	0.97		0.32	0.29	0.98	0.99	0.99	0.99	0.9	0.67	0.51	0.87	0.56	0.9	0.81
Income Before Tax	0.19	0.32	0.18	0.19	0.36	0.21	0.35	0.19	0.05	0.25	0.32		1.0	0.26	0.3	0.31	0.29	0.22	0.24	0.06	0.18	0.05	0.23	0.28
Total Other Income Expense Net	0.19	0.29	0.15	0.16	0.34	0.17	0.32	0.15	0.04	0.22	0.29	1.0		0.22	0.27	0.28	0.25	0.19	0.22	0.05	0.15	0.03	0.2	0.26
Selling And Marketing Expenses	0.32	0.98	0.95	0.96	0.89	0.98	0.96	0.92	0.53	0.99	0.98	0.26	0.22		0.99	0.98	0.99	0.92	0.55	0.53	0.88	0.57	0.93	0.76
Total Revenue	0.37	1.0	0.94	0.95	0.92	0.97	0.99	0.92	0.48	0.98	0.99	0.3	0.27	0.99		1.0	1.0	0.92	0.65	0.49	0.86	0.53	0.92	0.83
Gross Profit	0.41	1.0	0.94	0.95	0.94	0.96	0.99	0.91	0.46	0.97	0.99	0.31	0.28	0.98	1.0		0.99	0.92	0.63	0.46	0.84	0.49	0.92	0.84
Cost Of Revenue	0.31	0.99	0.95	0.96	0.89	0.97	0.98	0.92	0.52	0.98	0.99	0.29	0.25	0.99	1.0	0.99		0.93	0.66	0.52	0.89	0.59	0.92	0.81
Net Income From Continuing Ops	0.36	0.9	0.98	0.97	0.76	0.96	0.87	1.0	0.27	0.91	0.9	0.22	0.19	0.92	0.92	0.92	0.93		0.53	0.27	0.85	0.53	0.87	0.73
Non Operating Income Net Other	0.19	0.67	0.53	0.53	0.63	0.54	0.66	0.53	0.3	0.57	0.67	0.24	0.22	0.55	0.65	0.63	0.66	0.53		0.3	0.59	0.39	0.55	0.78
Tax Provision	-0.37	0.49	0.45	0.47	0.35	0.5	0.46	0.27	1.0	0.57	0.51	0.06	0.05	0.53	0.49	0.46	0.52	0.27	0.3		0.65	0.74	0.53	0.16
Interest Income	0.01	0.85	0.89	0.89	0.65	0.9	0.8	0.85	0.65	0.89	0.87	0.18	0.15	0.88	0.86	0.84	0.89	0.85	0.59	0.65		0.86	0.8	0.57
Net Interest Income	-0.5	0.51	0.61	0.59	0.25	0.6	0.44	0.53	0.74	0.63	0.56	0.05	0.03	0.57	0.53	0.49	0.59	0.53	0.39	0.74	0.86		0.53	0.13
Reconciled Depreciation	0.27	0.91	0.91	0.93	0.82	0.94	0.9	0.87	0.53	0.93	0.9	0.23	0.2	0.93	0.92	0.92	0.92	0.87	0.55	0.53	0.8	0.53		0.74
Extraordinary Items	0.66	0.85	0.7	0.74	0.91	0.74	0.87	0.73	0.16	0.73	0.81	0.28	0.26	0.76	0.83	0.84	0.81	0.73	0.78	0.16	0.57	0.13	0.74

Click cells to compare fundamentals

DexCom Account Relationship Matchups

DexCom income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	84.7M	102M	18.6M	20.3M	19M	15.7M
Other Operating Expenses	1.6B	2.2B	2.5B	3.0B	3.4B	3.6B
Operating Income	299.5M	175.4M	391.2M	597.7M	600M	630M
Ebit	309.7M	275.6M	409.4M	730.7M	623.0M	654.1M
Research Development	359.9M	604.2M	484.2M	505.8M	552.4M	580.0M
Ebitda	376.8M	377.5M	565.3M	916.7M	840.7M	882.7M
Total Operating Expenses	980.6M	1.4B	1.5B	1.7B	1.9B	2.0B
Net Income	493.6M	154.7M	341.2M	541.5M	576.2M	605.0M
Income Tax Expense	(268.6M)	19.2M	49.6M	168.9M	132.8M	139.4M
Depreciation And Amortization	67.1M	101.9M	155.9M	186M	217.7M	228.6M
Selling General Administrative	544.2M	684.1M	867.2M	1.0B	1.3B	1.4B
Income Before Tax	225M	173.9M	390.8M	710.4M	709M	744.5M
Total Other Income Expense Net	(38.1M)	(74.5M)	(9M)	112.7M	109M	114.5M
Selling And Marketing Expenses	76.5M	126.4M	133M	180.8M	207.9M	218.3M
Total Revenue	1.9B	2.4B	2.9B	3.6B	4.0B	4.2B
Gross Profit	1.3B	1.7B	1.9B	2.3B	2.5B	2.6B
Cost Of Revenue	646.6M	768M	1.0B	1.3B	1.6B	1.6B
Net Income From Continuing Ops	493.6M	154.7M	341.2M	541.5M	576.2M	605.0M
Net Income Applicable To Common Shares	101.1M	493.6M	154.7M	341.2M	392.4M	412.0M
Tax Provision	(268.6M)	19.2M	49.6M	168.9M	132.8M	139.4M
Interest Income	16.1M	1.7M	18M	135M	134.2M	140.9M
Net Interest Income	(68.6M)	(100.3M)	(18.6M)	114.7M	115.2M	121.0M
Reconciled Depreciation	67.1M	102M	155.9M	186M	217.7M	113.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:

How To Invest In DexCom

Details

Is DexCom Stock a good investment?

Details

What is DexCom's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.39)

Earnings Share

1.42

Revenue Per Share

10.246

Quarterly Revenue Growth

0.076

Return On Assets

0.0588

The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

DexCom Historical Income Statement

About DexCom Income Statement Analysis

DexCom Income Statement Chart

Total Operating Expenses

Depreciation And Amortization

DexCom income statement Correlations

DexCom Account Relationship Matchups

High Positive Relationship

High Negative Relationship

DexCom income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Total Revenue	+ 1.0	Other Operating Expenses
Gross Profit	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Net Income From Continuing Ops	+ 1.0	Net Income
Tax Provision	+ 1.0	Income Tax Expense

Net Interest Income	- 0.5	Interest Expense
Income Tax Expense	- 0.38	Interest Expense
Tax Provision	- 0.37	Interest Expense